Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-28T11:36:52.492Z Has data issue: false hasContentIssue false

New drugs and the NHS

Published online by Cambridge University Press:  02 January 2018

John Kellett*
Affiliation:
The Chalet Mount Gardens, London SE26 4NY
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1999 The Royal College of Psychiatrists

References

Goodkin, D. E. (1998) Interferon beta therapy for multiple sclerosis. Lancet, 352, 14861487.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.